Multiple sclerosis in Central America and Caribbean countries: frequency and clinical characterization of an emergent disease

Multiple Sclerosis (MS) is a common neurological disease among white populations of European origin. Frequencies among Latin Americans continue to be studied, however, epidemiologic, and clinical characterization studies lack from Central American and Caribbean countries. Ethnicity in these countrie...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in Epidemiology (Online) Vol. 4; p. 1368675
Main Authors: Gracia, Fernando, Ramírez Navarro, Deyanira A, Ramírez Sánchez, Nicia E, Weiser, Roberto, Parajeles-Vindas, Alexander, Portillo Rivera, Ligia I, Torres, Ericka López, García Valle, Luis A, Sanabria-Castro, Alfredo, Abdón López, César, Araujo, Pahola, Ayerdis Zamora, Maria J, Balmaceda-Meza, Andrea, Benzadon Cohen, Aron, Candelario Cueto, Awilda, Castillo, Diego, Castro-Escobar, Romy, Corea Urbina, Karla Z, de Peña Rivas, Anyeri, Sotelo, Octavio Duarte, Enamorado Claros, Temís, Giroud Benítez, José L, Gracia, Karla, Larreategui, Mario, Martínez Cerrato, Jorge A, Medina Báez, Josmarlin P, Menjivar Samayoa, Carlos E, Miranda-Loria, Gustavo, Monterrey-Alvarez, Priscilla, Morales Arguello, Lilliam A, Ortiz, Michelle, Pérez Baldioceda, Carlos D, Pinilla Aguilar, Lizeth, Salinas, Luis C Rodríguez, Rodríguez-Moreno, Virginia, Rojas-Chaves, Sebastián, Román-Garita, Norbel, Santos Pujols, Biany, Valderrama, Carlos, Van Sijtveld, Ivonne, Zabala Angeles, Indhira, Rivera, Victor M, Armien, Blas
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Multiple Sclerosis (MS) is a common neurological disease among white populations of European origin. Frequencies among Latin Americans continue to be studied, however, epidemiologic, and clinical characterization studies lack from Central American and Caribbean countries. Ethnicity in these countries is uniformly similar with a prevalent Mestizo population. Data from January 2014 to December 2019 from Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Panama, Dominican Republic, and Aruba on demographic, clinical, MRI and phenotypic traits were determined in coordinated studies: ENHANCE, a population-based, retrospective, observational study on incidence and clinical characteristics, and from the subgroup with MS national registries (Aruba, Dominican Republic, Honduras, and Panama), data on prevalence, phenotypes and demographics. Expanded Disability Status Scale (EDSS), and therapeutic schemes were included. ENHANCE data from 758 patients disclosed 79.8% of Mestizo ethnicity; 72.4% female; median age at onset 31.0 years and 33.2 at diagnosis. The highest incidence rate was from Aruba, 2.3-3.5 × 100,000 inhabitants, and the lowest, 0.07-0.15 × 100,000, from Honduras. Crude prevalence rates per 100,000 inhabitants fluctuated from 27.3 (Aruba) to 1.0 (Honduras). Relapsing MS accounted for 87.4% of cases; EDSS <3.0 determined in 66.6% (mean disease duration: 9.1 years, SD ± 5.0); CSF oligoclonal bands 85.7%, and 87% of subjects hydroxyvitamin D deficient. Common initial therapies were interferon and fingolimod. Switching from interferon to fingolimod was the most common escalation step. The COVID-19 pandemic affected follow-up aspects of these studies. This is the first study providing data on frequencies and clinical characteristics from 8 countries from the Central American and Caribbean region, addressing MS as an emergent epidemiologic disorder. More studies from these areas are encouraged.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Andrei Ivashynka, Moriggia Pelascini Hospital, Italy
Berenice Temoteo Silva, Federal University of Bahia, Brazil
Edited by: Steve Simpson-Yap, The University of Melbourne, Australia
William Bevens, University of California, Irvine, United States
ISSN:2674-1199
2674-1199
DOI:10.3389/fepid.2024.1368675